Industry Experts

Leila Delamarre is a Principal Scientist in the Cancer Immunology Department at Genentech, where she focuses on developing novel strategies to enhance T cell priming and expand effective anti-tumor immune responses. She joined Genentech in 2007 following her postdoctoral training at Yale University, where her research explored the cellular mechanisms that enable dendritic cells to capture and present antigens for T cell activation.

At Genentech, Leila has continued to pursue her passion for tumor immunology, working collaboratively across scientific disciplines to drive innovation in cancer immunotherapy. She is deeply committed to translating scientific insights into impactful therapies and is continually inspired by the collaborative and dynamic research environment around her.